These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 39101490)
1. Systemic administration of Resolvin D1 reduces cancer-induced bone pain in mice: Lack of sex dependency in pain development and analgesia. Flippen A; Khasabova IA; Simone DA; Khasabov SG Cancer Med; 2024 Aug; 13(15):e70077. PubMed ID: 39101490 [TBL] [Abstract][Full Text] [Related]
2. Intrathecal administration of Resolvin D1 and E1 decreases hyperalgesia in mice with bone cancer pain: Involvement of endocannabinoid signaling. Khasabova IA; Golovko MY; Golovko SA; Simone DA; Khasabov SG Prostaglandins Other Lipid Mediat; 2020 Dec; 151():106479. PubMed ID: 32745525 [TBL] [Abstract][Full Text] [Related]
3. Characterization of commercially available murine fibrosarcoma NCTC-2472 cells both in vitro and as a model of bone cancer pain in vivo. Ortiz YT; Shamir LG; McMahon LR; Wilkerson JL PLoS One; 2024; 19(8):e0309398. PubMed ID: 39208033 [TBL] [Abstract][Full Text] [Related]
5. Analgesic effects of a soy-containing diet in three murine bone cancer pain models. Zhao C; Wacnik PW; Tall JM; Johns DC; Wilcox GL; Meyer RA; Raja SN J Pain; 2004 Mar; 5(2):104-10. PubMed ID: 15042518 [TBL] [Abstract][Full Text] [Related]
6. Resolvin D1 suppresses inflammation-induced hyperexcitability of nociceptive trigeminal neurons associated with mechanical hyperalgesia. Ikeda A; Muroki A; Suzuki C; Shimazu Y; Takeda M Brain Res Bull; 2020 Jan; 154():61-67. PubMed ID: 31722251 [TBL] [Abstract][Full Text] [Related]
7. Effects of D-series resolvins on behavioral and neurochemical changes in a fibromyalgia-like model in mice. Klein CP; Sperotto ND; Maciel IS; Leite CE; Souza AH; Campos MM Neuropharmacology; 2014 Nov; 86():57-66. PubMed ID: 24929111 [TBL] [Abstract][Full Text] [Related]
9. Enduring prevention and transient reduction of postoperative pain by intrathecal resolvin D1. Huang L; Wang CF; Serhan CN; Strichartz G Pain; 2011 Mar; 152(3):557-565. PubMed ID: 21255928 [TBL] [Abstract][Full Text] [Related]
10. Resolution of Inflammation by Resolvin D1 Is Essential for Peroxisome Proliferator-activated Receptor-γ-mediated Analgesia during Postincisional Pain Development in Type 2 Diabetes. Saito T; Hasegawa-Moriyama M; Kurimoto T; Yamada T; Inada E; Kanmura Y Anesthesiology; 2015 Dec; 123(6):1420-34. PubMed ID: 26492476 [TBL] [Abstract][Full Text] [Related]
11. Colocalization of aromatase in spinal cord astrocytes: differences in expression and relationship to mechanical and thermal hyperalgesia in murine models of a painful and a non-painful bone tumor. O'Brien EE; Smeester BA; Michlitsch KS; Lee JH; Beitz AJ Neuroscience; 2015 Aug; 301():235-45. PubMed ID: 26071956 [TBL] [Abstract][Full Text] [Related]
12. Resolvin D1 reverses chronic pancreatitis-induced mechanical allodynia, phosphorylation of NMDA receptors, and cytokines expression in the thoracic spinal dorsal horn. Quan-Xin F; Fan F; Xiang-Ying F; Shu-Jun L; Shi-Qi W; Zhao-Xu L; Xu-Jie Z; Qing-Chuan Z; Wei W BMC Gastroenterol; 2012 Oct; 12():148. PubMed ID: 23092159 [TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of aspirin-triggered resolvin D1 on spinal nociceptive processing in rat pain models. Meesawatsom P; Burston J; Hathway G; Bennett A; Chapman V J Neuroinflammation; 2016 Sep; 13(1):233. PubMed ID: 27589850 [TBL] [Abstract][Full Text] [Related]
14. The relationship of bone-tumor-induced spinal cord astrocyte activation and aromatase expression to mechanical hyperalgesia and cold hypersensitivity in intact female and ovariectomized mice. Smeester BA; O'Brien EE; Michlitsch KS; Lee JH; Beitz AJ Neuroscience; 2016 Jun; 324():344-54. PubMed ID: 26995084 [TBL] [Abstract][Full Text] [Related]
15. 17(R)-resolvin D1 specifically inhibits transient receptor potential ion channel vanilloid 3 leading to peripheral antinociception. Bang S; Yoo S; Yang TJ; Cho H; Hwang SW Br J Pharmacol; 2012 Feb; 165(3):683-92. PubMed ID: 21718307 [TBL] [Abstract][Full Text] [Related]
16. Resolvin D1 Inhibits Mechanical Hypersensitivity in Sciatica by Modulating the Expression of Nuclear Factor-κB, Phospho-extracellular Signal-regulated Kinase, and Pro- and Antiinflammatory Cytokines in the Spinal Cord and Dorsal Root Ganglion. Liu ZH; Miao GS; Wang JN; Yang CX; Fu ZJ; Sun T Anesthesiology; 2016 Apr; 124(4):934-44. PubMed ID: 26808633 [TBL] [Abstract][Full Text] [Related]
17. Increasing 2-arachidonoyl glycerol signaling in the periphery attenuates mechanical hyperalgesia in a model of bone cancer pain. Khasabova IA; Chandiramani A; Harding-Rose C; Simone DA; Seybold VS Pharmacol Res; 2011 Jul; 64(1):60-7. PubMed ID: 21440630 [TBL] [Abstract][Full Text] [Related]
18. Polyunsaturated fatty acid-derived lipid mediator Resolvin D1 alleviates sepsis-induced disseminated intravascular coagulation via Caspase-1/Gasdermin D pyroptotic pathway. Zhang W; Bhandari S; Ding Y; Luo J; Feng B; Jiang Y; Chen T; Wei J; Pan X; Weng H; Ding Z; Chen J; Chen X; Gong Y; Li H; Jin S; Hao Y Clin Nutr; 2024 Jun; 43(6):1372-1383. PubMed ID: 38678822 [TBL] [Abstract][Full Text] [Related]
19. Palliation of bone cancer pain by antagonists of platelet-activating factor receptors. Morita K; Shiraishi S; Motoyama N; Kitayama T; Kanematsu T; Uezono Y; Dohi T PLoS One; 2014; 9(3):e91746. PubMed ID: 24637403 [TBL] [Abstract][Full Text] [Related]